Development of interferon-β as a therapy for multiple sclerosis

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.9, Iss.2, 2004-11, pp. : 363-374

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improving Compliance with Interferon-β Therapy in Patients with Multiple Sclerosis

By Portaccio Emilio >

CNS Drugs, Vol. 23, Iss. 6, 2009-05 ,pp. : 453-462

Adis International

Access to resources Recommend Favorite

Haematological Effects of Interferon-β-1a (Rebif ® ) Therapy in Multiple Sclerosis

By Rieckmann Peter

Drug Safety, Vol. 27, Iss. 10, 2004-01 ,pp. : 745-756

Adis International

Access to resources Recommend Favorite

Interferon-β_1b for the treatment of multiple sclerosis

By Lam Sum Wang Shan Gottesman Malcolm

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 8, 2008-08 ,pp. : 1111-1117

Informa Healthcare

Access to resources Recommend Favorite

The Mechanism of Action of Interferon-β in Relapsing Multiple Sclerosis

By Kieseier Bernd C.

CNS Drugs, Vol. 25, Iss. 6, 2011-06 ,pp. : 491-502

Adis International

Access to resources Recommend Favorite

Interferon-β_1b in the treatment of multiple sclerosis

By Río Jordi Montalban Xavier

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2877-2886

Informa Healthcare

Access to resources Recommend Favorite